Statistics for Werewolf Therapeutics, (id:8377 HOWL)
Valuation metrics
Market cap
73.08M
Enterprise value
-12,965,429.00
Trailing P/E (ttm)
-1.81
Forward P/E
-0.90
PEG ratio
-0.90
Price/Sales (ttm)
21.58
Price/Book (mrq)
0.80
Enterprise Value/Revenue
-3.83
Enterprise Value/EBITDA
0.20
Overview
Shares outstanding
44.56M
Float
25.62M
Shares short
1.23M
% Held by insiders
0.06%
% Held by institutions
0.73%
Average volume (10 days)
618.08K
Average volume (90 days)
Price summary
52-Week low
1.58
52-Week high
8.19
52-Week change
-32.63%
Beta
0.41
50-Day moving average
2.26
200-Day moving average
3.88
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-1,955.35%
Operational effectiveness
Return on assets
-26.16%
Return on equity
-61.56%
Income statement
Revenue (ttm)
0.08
Revenue per share (ttm)
0.08
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-64,376,000.00
Net income to common (ttm)
-62,118,000.00
Diluted EPS (ttm)
-1.52
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
122.83M
Total cash per share (mrq)
2.76
Total debt (mrq)
36.78M
Total Debt/Equity (mrq)
41.15
Current ratio (mrq)
1.01K%
Book value per share (mrq)
2.04
Cash flow
Cash flow statement
-46,521,000.00
Levered free cash flow (LFCF)
-27,666,376.00